Biomarker-guided Repurposing

Biomarker-Guided Repurposing is a drug repurposing strategy that systematically uses predictive molecular or clinical biomarkers to identify new therapeutic indications and responsive patient subpopulations for already approved drugs, particularly chemotherapeutic agents.

26

Publications

1.7K

Citations

211

Authors

111

Institutions

Publications per year

2017–2026

19

Authors

211

  1. FZ
    Faı̈ez Zannad

    Inserm, France

    2 publications · 63 citations

    2

    h-index

  2. AA
    Adriaan A. Voors

    University Medical Center Groningen, Netherlands

    2 publications · 63 citations

    2

    h-index

  3. TI
    Tudor I. Oprea

    University of New Mexico, United States

    2 publications · 660 citations

    2

    h-index

  4. SD
    Stefan D. Anker

    Charité - Universitätsmedizin Berlin, Germany

    2 publications · 65 citations

    2

    h-index

  5. AW
    Angela Wandinger‐Ness

    University of New Mexico, United States

    1 publications · 369 citations

    1

    h-index

1–5 of 211

Venues

  1. Nature Chemical Biology

    2 publications · 120 citations

    2

    h-index

  2. Journal of the American College of Cardiology

    JACC · 2 publications · 79 citations

    2

    h-index

  3. European Journal of Heart Failure

    2 publications · 66 citations

    2

    h-index

  4. Nature Communications

    1 publications · 297 citations

    2

    h-index

  5. Computers in Biology and Medicine

    1 publications · 36 citations

    2

    h-index

1–5